Dr. Grant D. Gilliland, MD

Dr. Gilliland practices at Baylor University Medical Center in Dallas, Texas, part of Baylor Scott & White Health.

Dr. Gilliland's NPI, 1619912631, was assigned on June 17, 2006. Dr. Gilliland graduated from UT Southwestern Medical Center in 1988. Dr. Gilliland holds Texas license H6240.

Dr. Gilliland's primary practice is Baylor University Medical Center, at 3500 Gaston Ave, Dallas, TX 75246 in Dallas County. The practice phone is (214) 820-8082.

Dr. Gilliland's primary practice is Baylor University Medical Center in Dallas, Texas, part of Baylor Scott & White Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gilliland practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Gilliland's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Gilliland is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Gilliland's licenses on file in 3 states: Texas, Oregon and Oklahoma.

Dmand AI lists conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, shingles and vision problems among the conditions Dr. Gilliland treats.

CMS data shows 3,257 Medicare services from Dr. Gilliland across 21 procedure codes in 2024, for 337 Medicare patients. Medicare paid $133,371 for them.

CMS counts 337 Medicare patients who saw Dr. Gilliland in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gilliland's median patient age at 66, with 63% women.

In 2024, Dr. Gilliland wrote 483 Medicare Part D claims for 188 patients. 93% of them were for generic drugs. CMS names the drug for 424 of them, across 6 drugs with 11 or more claims each, at $5,973 in total drug cost. In 2023, CMS named 490 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gilliland for performance year 2024, reported individually. Dr. Gilliland accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 51 procedures of melanoma (skin cancer) excision by Dr. Gilliland, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Gilliland, published from 2012 to 2023. 2012 was the busiest year, with 2. The most frequent topics are Biocompatible Materials, Decompression, Surgical and Durapatite. Dr. Gilliland has published most often in Proc (Bayl Univ Med Cent). Dr. Gilliland's most frequent co-authors are Ivan M. Vrcek, MD, Victoria Sheila Starks, MD and Kennith F. Layton, MD.

CMS Open Payments shows 10 general payments to Dr. Gilliland from 6 drug and device companies from 2017 to 2025. Honoraria make up the largest share, 70% of the total. Horizon Pharma plc paid the most, $1,431.

Dmand AI lists 5 awards for Dr. Gilliland, most recently Top 'Doctor in 2017.

Dr. Gilliland graduated from UT Southwestern Medical Center in 1988. Dr. Gilliland is a member of AOA, AAO, American Society of Oculofacial Plastic, Reconstructive & Orbital Surgery and ASPS.

Dr. Gilliland is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.